It is plausible that low-concentration, chronic GM-CSF stimulation induces MDSCs through negative feedback loops, whereas high-concentration, acute GM-CSF stimulation as applied in neuroblastoma therapy, activates neutrophils. Here, CSF2 is linked to neuroblastoma.